Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
Aim for at least 8 glasses of water a day
Thats about it. A 2024 report from financial services firm KPMG estimates that GLP-1 drug users caloric intake declined 21%, and their monthly grocery spending fell by 31%
They were not waiting long enough
Our platform is designed to make the process as simple as possible
The peptides for brain health category is expanding, and semaglutide growing evidence base in neuroprotection positions it as a molecule of particular interest for cognitive research